Rhumbline Advisers Avanos Medical, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 143,843 shares of AVNS stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
143,843
Previous 145,859 1.38%
Holding current value
$2.37 Million
Previous $3.5 Million 34.67%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$15.58 - $23.61 $31,409 - $47,597
-2,016 Reduced 1.38%
143,843 $2.29 Million
Q3 2024

Nov 12, 2024
SELL
$19.21 - $24.69 $54,671 - $70,267
-2,846 Reduced 1.91%
145,859 $3.5 Million
Q2 2024

Aug 01, 2024
SELL
$17.85 - $20.42 $69,704 - $79,740
-3,905 Reduced 2.56%
148,705 $2.96 Million
Q1 2024

May 09, 2024
SELL
$17.97 - $22.68 $59,983 - $75,705
-3,338 Reduced 2.14%
152,610 $3.04 Million
Q4 2023

Feb 08, 2024
BUY
$17.64 - $22.99 $6,473 - $8,437
367 Added 0.24%
155,948 $3.5 Million
Q3 2023

Nov 09, 2023
SELL
$19.93 - $26.31 $42,709 - $56,382
-2,143 Reduced 1.36%
155,581 $3.15 Million
Q2 2023

Aug 08, 2023
SELL
$22.53 - $30.98 $93,814 - $129,000
-4,164 Reduced 2.57%
157,724 $4.03 Million
Q1 2023

May 11, 2023
BUY
$26.92 - $31.75 $117,990 - $139,160
4,383 Added 2.78%
161,888 $4.82 Million
Q4 2022

Feb 14, 2023
BUY
$19.88 - $27.37 $164,467 - $226,432
8,273 Added 5.54%
157,505 $4.26 Million
Q3 2022

Nov 10, 2022
BUY
$21.56 - $29.59 $77,766 - $106,731
3,607 Added 2.48%
149,232 $3.25 Million
Q2 2022

Aug 11, 2022
BUY
$24.87 - $34.68 $68,442 - $95,439
2,752 Added 1.93%
145,625 $3.98 Million
Q1 2022

May 12, 2022
BUY
$28.87 - $35.77 $4,676 - $5,794
162 Added 0.11%
142,873 $4.79 Million
Q4 2021

Feb 10, 2022
BUY
$29.25 - $36.02 $178,805 - $220,190
6,113 Added 4.48%
142,711 $4.95 Million
Q3 2021

Nov 12, 2021
SELL
$31.2 - $38.5 $539,104 - $665,241
-17,279 Reduced 11.23%
136,598 $4.26 Million
Q2 2021

Aug 05, 2021
SELL
$36.37 - $45.72 $70,194 - $88,239
-1,930 Reduced 1.24%
153,877 $5.6 Million
Q1 2021

May 06, 2021
SELL
$43.5 - $53.4 $241,773 - $296,797
-5,558 Reduced 3.44%
155,807 $6.82 Million
Q4 2020

Feb 10, 2021
BUY
$33.15 - $49.5 $272,957 - $407,583
8,234 Added 5.38%
161,365 $7.4 Million
Q3 2020

Nov 12, 2020
SELL
$28.67 - $34.32 $434,149 - $519,707
-15,143 Reduced 9.0%
153,131 $5.09 Million
Q2 2020

Aug 13, 2020
BUY
$23.48 - $33.86 $66,824 - $96,365
2,846 Added 1.72%
168,274 $4.95 Million
Q1 2020

May 06, 2020
BUY
$20.64 - $34.41 $148,092 - $246,891
7,175 Added 4.53%
165,428 $4.46 Million
Q4 2019

Feb 05, 2020
SELL
$31.89 - $47.34 $187,353 - $278,122
-5,875 Reduced 3.58%
158,253 $5.33 Million
Q3 2019

Oct 23, 2019
BUY
$32.06 - $44.0 $170,046 - $233,376
5,304 Added 3.34%
164,128 $6.15 Million
Q2 2019

Aug 14, 2019
BUY
$37.68 - $46.52 $51,433 - $63,499
1,365 Added 0.87%
158,824 $6.93 Million
Q1 2019

May 01, 2019
BUY
$39.84 - $51.04 $109,520 - $140,308
2,749 Added 1.78%
157,459 $6.72 Million
Q4 2018

Jan 31, 2019
BUY
$41.16 - $66.67 $2.62 Million - $4.24 Million
63,646 Added 69.89%
154,710 $6.93 Million
Q3 2018

Nov 07, 2018
BUY
$55.13 - $72.65 $5.02 Million - $6.62 Million
91,064 New
91,064 $6.24 Million

Others Institutions Holding AVNS

# of Institutions
269
Shares Held
42.8M
Call Options Held
5.4K
Put Options Held
5K
View Full List

About AVANOS MEDICAL, INC.

AVNS Quotes by TradingView
  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $768M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email